Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Sonio

company

About

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations.

Details

Last Funding Type
Seed
Last Funding Money Raised
€7.50M
Industries
Artificial Intelligence,Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Sonio SAS

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€15M
Sonio has raised a total of €15M in funding over 2 rounds. Their latest funding was raised on Dec 21, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 21, 2022 Seed €7.50M 1 European Innovation Council Detail
Dec 21, 2022 Grant €2.50M 1 European Innovation Council Detail
Jun 30, 2022 Seed €5M 3 Bpifrance
Elaia
OneRagtime
Detail

Investors

Number of Lead Investors
Number of Investors
5
4
Sonio is funded by 4 investors. European Innovation Council and Bpifrance are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Seed
Bpifrance Yes Seed
Elaia Yes Seed
OneRagtime Yes Seed

Employee Profiles

Number of Employee Profiles
7
Sonio has 7 current employee profiles, including Executive Cecile Brosset
Executive
Executive
Executive
Executive